Skip to main content

Table 3 Frequency distribution of patients hospitalized for Covid-19 Pneumonia, according to the outcome (dead/alive) and its associated factors

From: Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia

Variables

Outcome

Wald test

p-value

OR

95% confidence interval

Adjusted

OR

95% confidence interval

Death

(n = 37)

Alive

(n = 264)

Lower

Upper

Lower

Upper

Colchicine

14

(37.8%)

131

(0.5%)

0.18

0.618

0.305

1.253

0.899

0.211

3.83

Comorbidities

34

(91.9%)

191

(72.3%)

0.018

4.332

1.291

14.539

4.827

0.324

71.83

Hypertension

20

(54.1%)

117

(44.3%)

0.267

1.478

0.741

2.949

0.624

0.065

6.02

Diabetes Mellitus

10

(27%)

63

(23.9%)

0.674

1.182

0.542

2.575

5.909

0.609

57.361

Obesity

7

(18.9%)

35

(13.3%)

0.355

1.527

0.623

3.741

0.508

0.061

4.267

Hypothyroidism

5

(13.5%)

24 (9.1%)

0.4

1.56

0.56

4.38

0.247

0.017

3.559

Renal Failure/Injury

18

(48.6%)

36

(13.6%)

 < 

0.001

6

2.879

12.504

12.452

1.301

119.165

Coronary Disease

4

(10.8%)

13 (4.9%)

0.2

2.17

0.67

6.97

15.932

0.721

352.075

COPD

5

(13.5%)

25 (9.5%)

0.44

1.49

0.53

4.18

1.013

0.167

6.145

Dementia

4

(10.8%)

8 (3%)

0.034

3.879

1.107

13.59

294.178

4.054

21,349.556

Cancer

7

(18.9%)

9 (3.4%)

 < 

0.001

6.611

2.296

19.038

589.909

17.691

19,670.832

Dyslipidemia

2 (5.4%)

25 (9.5%)

0.42

0.55

0.12

2.41

1.394

0.075

25.897

Autoimmune

Disease

2 (5.4%)

5 (1.9%)

0.21

2.96

0.55

15.84

25.119

0.494

1276.397

Psychiatric Disease

1 (2.7%)

6 (2.3%)

0.87

1.19

0.14

10.21

3.291

0.039

280.52

Neurological

Disease

2 (5.4%)

9 (3.4%)

0.55

1.62

0.34

7.8

0.362

0.001

99.943

Heart Disease

1 (2.7%)

6 (2.3%)

0.87

1.19

0.14

10.21

5.493

0

65,179.579

Secondary Infection

10

(27%)

16 (6.1%)

 < 

0.001

5.741

2.371

13.9

0.097

0.007

1.289

Shock

24

(64.9%)

18 (6.8%)

 < 

0.001

25.23

1

11.031

57.712

1802.79

9

16.195

200,680.618

Co-Infection

7

(18.9%)

16 (6.1%)

0.009

3.617

1.377

9.499

15.925

0.845

300.105

ARDS

35

(94.6%)

180

(68.2%)

0.004

8.167

1.919

34.756

0.174

0.002

13.756

Mild

(n = 236)

2 (5.4%)

70

(26.5%)

0.003

9.154

2.14

39.24

0.158

0

28,166,402.9

5

Moderate

(n = 236)

10

(27%)

62

(23.5%)

0.7

1.168

0.531

2.57

0.005

0

73.57

Severe

(n = 237)

25

(67.6%)

67

(25.4%)

 < 

0.001

4.545

2.11

9.792

1645.53

4

0.091

29,789,951.2

9

Mechanical

Ventilation

20

(54.1%)

37 (14%)

 < 

0.001

8.144

3.83

17.316

0.178

0.003

10.675

High-FlowNasal

Canula

32

(86.5%)

104

(39.4%)

0.03

0.083

0.0284

0.241

0.069

0.0038

0.63

ICU admission

22

(59.5%)

83

(31.4%)

0.001

3.389

1.651

6.954

1.213

0.099

14.824

Lymphocytes

         

 (900,3300)

13

(35.1%)

138

(52.3%)

0.054

2.022

0.987

4.141

0.065

0.006

0.759

  < 900 or > 3300

24

(64.9%)

126

(47.7%)

Ferritin

  < 204

2 (5.4%)

31

(11.7%)

0.261

2.328

0.534

10.161

0.059

0.003

1.292

  > 204

35

(94.6%)

233

(88.3%)

LDH

  < 220

0 (0%)

36

(13.6%)

0.998

NA

  > 220

37

(100%)

228

(86.4%)

D-Dimer

  < 198

1 (2.7%)

19 (7.2%)

0.324

0.358

0.047

2.758

1.084

0

298,440.882

  > 198

36

(97.3%)

245

(92.8%)

Initial PaFi

  < 200

28

(75.7%)

95 (36%)

 < 0.001

5.535

2.507

12.219

0.472

0.053

4.228

  > 200

9

(24.3%)

169

(64%)

  < 300

34

(91.9%)

190

(72%)

0.016

4.414

1.315

14.812

2.57

0.094

70.038

  > 300

3 (8.1%)

74 (28%)

Lowest PaFi

  < 200

35

(94.6%)

140

(53%)

 < 0.001

15.5

3.653

65.769

1.399

0

1,870,118,737

  > 200

2 (5.4%)

124

(47%)

 < 300

37

(100%)

221

(83.7%)

0.997

NA